Innate Pharma (IPHA) Stock Chart & Stock Price History $1.48 +0.02 (+1.37%) Closing price 10/27/2026 04:00 PM EasternExtended Trading$1.49 +0.01 (+0.88%) As of 10/27/2026 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOwnershipSEC FilingsShort Interest Innate Pharma Stock Price Performance The Innate Pharma (IPHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 29.52%, with a year-to-date return of -15.43%. In the past month, the stock has decreased 12.94%, reflecting recent market activity. As of the latest close, Innate Pharma traded at $1.48 with a market cap of and volume of 16,815 shares. Five years ago, the stock traded at $5.99, representing a 75.29% decrease over that period. At the time, it had a market cap of and a volume of 98,629 shares. Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.33%1 Month Performance-12.94%3 Month Performance-17.78%Year-To-Date Performance-15.43%1 Year Performance-29.52%5 Year Performance-75.29% IPHA Stock Chart for Wednesday, October, 28, 2026 IPHA Chart by TradingView Innate Pharma Stock Price History Daily Weekly Monthly Yearly Interval 9/28/2026 - 10/28/2026 Price Date Price Date From Price Date To 1M3M6MYTD1Y3Y5Y More filters Fewer filters Done 0 Results Export DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/27/2026$1.46$1.48+1.37%$1.50$1.4516,815 shs$165.35 million10/26/2026$1.50$1.46-2.67%$1.54$1.4321,882 shs$163.11 million10/23/2026$1.50$1.50$1.52$1.4811,621 shs$167.58 million10/22/2026$1.57$1.50-4.46%$1.53$1.4132,699 shs$167.58 million10/21/2026$1.58$1.57-0.51%$1.60$1.5218,806 shs$175.40 million10/20/2026$1.46$1.58+8.08%$1.59$1.5013,133 shs$176.29 million10/19/2026$1.43$1.46+2.10%$1.50$1.468,315 shs$163.11 million10/16/2026$1.48$1.43-3.38%$1.53$1.438,028 shs$159.76 million10/15/2026$1.43$1.48+3.50%$1.58$1.467,234 shs$165.34 million10/14/2026$1.47$1.43-2.72%$1.47$1.429,275 shs$159.76 million Get the Latest News and Ratings for IPHA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/13/2026$1.48$1.47-0.68%$1.48$1.455,605 shs$164.23 million10/12/2026$1.62$1.48-8.64%$1.53$1.4633,803 shs$165.34 million10/09/2026$1.48$1.62+9.46%$1.68$1.4946,876 shs$180.99 million10/08/2026$1.52$1.48-2.63%$1.54$1.4718,360 shs$165.35 million10/07/2026$1.59$1.52-4.40%$1.55$1.5013,818 shs$169.81 million10/06/2026$1.58$1.59+0.63%$1.65$1.53133,729 shs$177.63 million10/05/2026$1.56$1.58+1.28%$1.69$1.53106,871 shs$176.52 million10/02/2026$1.59$1.56-1.89%$1.69$1.5392,739 shs$174.28 million10/01/2026$1.63$1.59-2.45%$1.67$1.5863,946 shs$177.64 million09/30/2026$1.60$1.63+1.87%$1.78$1.6137,805 shs$182.10 million09/29/2026$1.70$1.60-5.88%$1.67$1.5931,799 shs$178.75 million09/28/2026$1.70$1.70$1.79$1.6642,060 shs$189.92 million Related Companies AURA Stock Price Chart PHAR Stock Price Chart SVA Stock Price Chart MDXG Stock Price Chart SLDB Stock Price Chart CADL Stock Price Chart WVE Stock Price Chart OLMA Stock Price Chart AVTX Stock Price Chart NVCT Stock Price Chart Receive IPHA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IPHA) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredYesterday's deadline changed everythingIn June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times th...Behind the Markets | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
